Nu-Med Plus Announces the Selection of Brett J. Earl M.D as VP of Medical Marketing and to Their Board of Directors

SALT LAKE CITY, UT--(Marketwired - Apr 7, 2015) -  Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the appointment of Brett J. Earl M.D. to their Board of Directors and also an Officer of the Company.

Dr. Earl received his Medical Degree from the University of Nevada, Reno and is a board certified emergency physician in the State of Utah. He has been published numerous times and presently serves on a number of Medical Boards in Utah. After practicing Emergency Medicine for many years and seeing the benefits and limitations of traditional western medicine, Dr. Earl opted to study and practice Functional Medicine in Bountiful, Utah. "Having Dr. Earl become an Officer in our Company and a member of our Board will strengthen our company's ability to focus on high growth existing and impending markets where there are clearly well-defined needs recognized by the medical community," commented Mr. Jeff Robins, President and CEO of Nu-Med-Plus.

About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use. For more information please visit

Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

Contact Information:


Jeff Robins